| Host: |
Rabbit |
| Applications: |
WB/ELISA/IHC |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-RalBP1-associated Eps domain-containing protein 1 (597-646 aa) is suitable for use in Western Blot, ELISA and Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC-P 1:50-300ELISA 2000-20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
REPS1 |
| Gene ID: |
85021 |
| Uniprot ID: |
REPS1_HUMAN |
| Immunogen Region: |
597-646 aa |
| Specificity: |
REPS1 Polyclonal Antibody detects endogenous levels of REPS1 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human REPS1 at the amino acid range 597-646 |
| Post Translational Modifications | EGF stimulates phosphorylation on Tyr-residues. |
| Function | May coordinate the cellular actions of activated EGF receptors and Ral-GTPases. |
| Protein Name | Ralbp1-Associated Eps Domain-Containing Protein 1Ralbp1-Interacting Protein 1 |
| Database Links | Reactome: R-HSA-8856825Reactome: R-HSA-8856828 |
| Cellular Localisation | MembraneClathrin-Coated PitColocalize With Itsn1 At The Plasma Membrane In Structures That Are Most Probably Clathrin-Coated Pits |
| Alternative Antibody Names | Anti-Ralbp1-Associated Eps Domain-Containing Protein 1 antibodyAnti-Ralbp1-Interacting Protein 1 antibodyAnti-REPS1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
